Boehringer Ingelheim

Startseite
Deutschland
Ingelheim am Rhein
Boehringer Ingelheim

Driving healthcare innovation for people and animals.
Welcome to our Facebook channel. g.

We are a German research-driven pharmaceutical company and it’s our goal to improve the lives of humans and animals worldwide. Country-specific content may have been issued in the countries where we do business. Follow us for news about healthcare topics, our research & development and company updates. This is a place where you can share your thoughts, and connect with other people. We are looking forward to exchanging ideas and engaging in conversations! We want to ensure that this is a safe and informative environment and respectfully request that you follow our Community Guidelines:

• Be nice to each other, even if you disagree

• Be constructive and inspire further conversations

• Please do not provide diagnoses or treatment advice

• We don’t tolerate discriminatory or derogatory comments, hate speech, especially humiliation of people or groups of people

• We don’t tolerate threats and requests for violence against anyone or anything

• We don’t tolerate po*******hy, profanity, and other content that puts young people at risk

• Please don’t infringe on the applicable legislation (e. on data protection), copyrights or trademarks

• The comment function should not be misused as advertising space or for other off-topic subjects

• We don’t tolerate the promotion of illegal activities

You acknowledge that you, not Boehringer Ingelheim, are responsible for the contents of your submission. We reserve ourselves the right to delete or hide any content on our social media pages that violate the Community Guidelines.

10/12/2025

Your heart and kidneys are closely connected. When one is at risk, so is the other. That’s why early detection is key to protecting both. 🔑
Stay on top of your health with regular check-ups, screenings and open conversations with your doctor.
Learn more and take control today: https://www.boehringer-ingelheim.com/human-health/chronic-kidney-disease/about-chronic-kidney-disease

05/12/2025

Advocacy groups like Minkahz NETs Mission are essential in supporting and rallying those living with extrapulmonary neuroendocrine carcinoma (epNEC), a rare and aggressive type of cancer.

These organizations help patients and families better understand their diagnosis, explore their options and connect with others on a similar journey.

Community and awareness can help change lives. Read more: https://go.boehringer.com/Ua3u6

26/11/2025

Identifying specific mutations in tumors has transformed lung cancer care.

This paves the way for personalized healthcare strategies, enabling healthcare teams to better support people living with lung cancer.

Jenny, who was diagnosed with lung cancer, had a biomarker test taken which gave her hope and clarity. Watch her story to see how personalized care can truly make a difference.

21/11/2025

Extrapulmonary neuroendocrine carcinoma (epNEC) is a rare and aggressive subgroup of neuroendocrine carcinomas (NECs) occurring in multiple organs outside of the lung. With limited treatment options and a challenging prognosis, the median survival is just 7.7 months.

Our dedicated research efforts aim to transform this narrative and improve patient outcomes.

Discover more about ongoing initiatives and advancements in understanding epNEC: https://go.boehringer.com/rF1OC

21/11/2025

Surprised to learn your kidneys affect your heart? So was Lynn.

In the series, her powerful story and expert insights show that protecting your kidneys means protecting your heart—and it starts with a simple urine test.

Click here to watch Lynn’s full story: https://www.boehringer-ingelheim.com/human-health/chronic-kidney-disease/beats-change-lynns-story-cvd-and-ckd

19/11/2025

Biomarker testing is a key part of cancer care and helps to improve the cancer care path to each patient's unique needs. As more people undergo these important tests, it's crucial that they understand what the results mean for their healthcare options.

Knowing your biomarker status can guide decisions and empower you to play an active role in your cancer care journey.

Danielle Hicks, Chief Patient Officer at GO2 for Lung Cancer shared valuable insights that highlight the importance of raising awareness and understanding, so that everyone can make informed choices about their health.

17/11/2025

Small changes, big impact!

From managing blood pressure to staying active, everyday habits play an important role in protecting your heart and interconnected organs, like your kidneys.

Discover how simple tips can support your every day.

13/11/2025

Does your ferocious feline turn into a scaredy cat at the vet? Cats get stressed in unfamiliar situations so getting your cat used to transport can go a long way. Veterinarian and cat expert Dr. Teresa Baur-Rehme (Ludwig-Maximilians-Universität München) shares tips.

13/11/2025

Paper leaflets are hard to read, harder to fold back, and often end up in the trash without a second glance. But what if there was a smarter way?

💡Say hello to electronic product information (ePI) - a digital solution that could finally put an end to the paper chaos.

➡️ Discover how ePI is transforming the leaflet experience: go.boehringer.com/jT9Ay

11/11/2025

Extrapulmonary neuroendocrine carcinoma (epNEC) is an aggressive and often misdiagnosed type of cancer, occurring in multiple organs outside of the lung, including the breast, urogenital system, skin, head and neck.

By collaborating with dedicated patient organizations like Minkahz NETs Mission, we can advocate for greater awareness and resources for those affected – driving meaningful change.

Learn more about epNEC and the ongoing efforts to improve outcomes for patients: https://go.boehringer.com/YPy9_

09/11/2025

The impact biomarkers have on cancer care is profound.

In non-small cell lung cancer (NSCLC), one of them is known as HER2 mutations, and it can greatly affect how the disease progresses and behaves. Identifying these mutations is crucial for creating personalized cancer care plans.

Learn more about the role of biomarker testing: https://go.boehringer.com/SNNWs

05/11/2025

Biomarkers – like gene mutations, proteins, or other substances - are crucial in managing non-small cell lung cancer (NSCLC). For instance, HER2 mutations, present in some NSCLC cases, can lead to rapid cancer growth, influencing care decisions and outcomes.
By understanding biomarkers, oncologists can tailor cancer care to suit individual patients' needs.

Explore how these genetic insights are transforming lung cancer care: https://go.boehringer.com/IktE

Adresse

Boehringer Ingelheim GmbH, Binger Straße 173
Ingelheim Am Rhein
55216

Telefon

+496132770

Webseite

http://www.boehringer-ingelheim.com/

Benachrichtigungen

Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von Boehringer Ingelheim erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.